A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

NCT00244647 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Coronary Stent Restenosis

Interventions

DRUG: RESTEN-MP

Sponsor

Sarepta Therapeutics, Inc.